LOVELACE WOMENS HOSPITAL — History
CCN 320017 | 3-year financial timeline | COVID resilience: 42/100
🛡️ Public data only — no PHI permitted on this instance.
$199M
Latest Revenue (FY2022)
-1.6%
Revenue CAGR (3yr)
7.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $205M | $195M | $199M | +1.7% | -1.6% |
| Operating Expenses | $181M | $179M | $183M | +2.5% | +0.5% |
| Operating Margin | 11.7% | 8.5% | 7.9% | -8.1% | -18.1% |
| Net Income | $24M | $17M | $16M | -6.5% | -19.4% |
| Licensed Beds | 160 | 160 | 162 | +1.2% | +0.6% |
| Total Patient Days | 32,773 | 31,845 | 30,385 | -4.6% | -3.7% |
| Medicare Day % | 8% | 8% | 9% | +7.4% | +5.9% |
| Medicaid Day % | 5% | 3% | 3% | -17.5% | -28.3% |
COVID Impact & Recovery
Resilience Score: 42/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -3.2% ($205M → $199M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-1.6%
This Hospital
+7.6%
State Avg
Latest Margin
7.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $196M | 5.9% |
| FY2024 (proj) | $192M | 4.0% |
| FY2025 (proj) | $189M | 2.1% |